251 related articles for article (PubMed ID: 3656351)
1. Synthesis of potential anticancer agents: imidazo[4,5-c]pyridines and imidazo[4,5-b]pyridines.
Temple C; Rose JD; Comber RN; Rener GA
J Med Chem; 1987 Oct; 30(10):1746-51. PubMed ID: 3656351
[TBL] [Abstract][Full Text] [Related]
2. Potential antimitotic agents. Synthesis of some ethyl benzopyrazin-7-ylcarbamates, ethyl pyrido[3,4-b]pyrazin-7-ylcarbamates, and ethyl pyrido[3,4-e]-as-triazin-7-ylcarbamates.
Temple C; Rener GA
J Med Chem; 1990 Nov; 33(11):3044-50. PubMed ID: 2231603
[TBL] [Abstract][Full Text] [Related]
3. New anticancer agents: synthesis of 1,2-dihydropyrido[3,4-b]pyrazines (1-deaza-7,8-dihydropteridines).
Temple C; Wheeler GP; Elliott RD; Rose JD; Kussner CL; Comber RN; Montgomery JA
J Med Chem; 1982 Sep; 25(9):1045-50. PubMed ID: 7131483
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of potential anticancer agents. Preparation of some 1-deazapurines and pyrimidines.
Temple C; Smith BH; Elliott RD; Montgomery JA
J Med Chem; 1973 Mar; 16(3):292-4. PubMed ID: 4733113
[No Abstract] [Full Text] [Related]
5. 1,2-Dihydropyrido[3,4-b]pyrazines: structure-activity relationships.
Temple C; Wheeler GP; Elliott RD; Rose JD; Comber RN; Montgomery JA
J Med Chem; 1983 Jan; 26(1):91-5. PubMed ID: 6827530
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological activity of 3-substituted imidazo[1,2-a]pyridines as antiulcer agents.
Starrett JE; Montzka TA; Crosswell AR; Cavanagh RL
J Med Chem; 1989 Sep; 32(9):2204-10. PubMed ID: 2769690
[TBL] [Abstract][Full Text] [Related]
7. Antimitotic agents: synthesis of imidazo[4,5-c]pyridin-6-ylcarbamates and imidazo[4,5-b]pyridin-5-ylcarbamates.
Temple C
J Med Chem; 1990 Feb; 33(2):656-61. PubMed ID: 2299631
[TBL] [Abstract][Full Text] [Related]
8. Directed solid-phase synthesis of trisubstituted imidazo[4,5-c]pyridines and imidazo[4,5-b]pyridines.
Lemrová B; Smyslová P; Popa I; Oždian T; Zajdel P; Soural M
ACS Comb Sci; 2014 Oct; 16(10):558-65. PubMed ID: 25046560
[TBL] [Abstract][Full Text] [Related]
9. Antimitotic agents. Alterations at the 2,3-positions of ethyl (5-amino-1,2-dihydropyrido[3,4-b]pyrazin-7-yl)carbamates.
Temple C; Rener GA; Comber RN; Waud WR
J Med Chem; 1991 Nov; 34(11):3176-81. PubMed ID: 1956035
[TBL] [Abstract][Full Text] [Related]
10. Antiulcer agents. 3. Structure-activity-toxicity relationships of substituted imidazo[1,2-a]pyridines and a related imidazo[1,2-a]pyrazine.
Kaminski JJ; Perkins DG; Frantz JD; Solomon DM; Elliott AJ; Chiu PJ; Long JF
J Med Chem; 1987 Nov; 30(11):2047-51. PubMed ID: 3669012
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and antitumor activity of amino derivatives of pyridine-2-carboxaldehyde thiosemicarbazone.
Liu MC; Lin TS; Sartorelli AC
J Med Chem; 1992 Oct; 35(20):3672-7. PubMed ID: 1433178
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and structure--activity relationship (SAR) studies of imidazo[4,5-b]pyridine derived purine isosteres and their potential as cytotoxic agents.
Sajith AM; Abdul Khader KK; Joshi N; Reddy MN; Syed Ali Padusha M; Nagaswarupa HP; Nibin Joy M; Bodke YD; Karuvalam RP; Banerjee R; Muralidharan A; Rajendra P
Eur J Med Chem; 2015 Jan; 89():21-31. PubMed ID: 25462222
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological Potential and Synthetic Approaches of Imidazo[4,5-b]pyridine and Imidazo[4,5-c]pyridine Derivatives.
Krause M; Foks H; Gobis K
Molecules; 2017 Mar; 22(3):. PubMed ID: 28273868
[TBL] [Abstract][Full Text] [Related]
14. 1-Amino-substituted 4-methyl-5H-pyrido[3',4':4,5]pyrrolo[3,2-c]pyridines: a new class of antineoplastic agents.
Nguyen CH; Bisagni E; Pepin O; Pierré A; de Cointet P
J Med Chem; 1987 Sep; 30(9):1642-7. PubMed ID: 3625709
[TBL] [Abstract][Full Text] [Related]
15. Novel amino substituted tetracyclic imidazo[4,5-b]pyridine derivatives: Design, synthesis, antiproliferative activity and DNA/RNA binding study.
Lončar B; Perin N; Mioč M; Boček I; Grgić L; Kralj M; Tomić S; Stojković MR; Hranjec M
Eur J Med Chem; 2021 May; 217():113342. PubMed ID: 33751978
[TBL] [Abstract][Full Text] [Related]
16. Design and synthesis of new imidazo[1,2-a]pyridine and imidazo[1,2-a]pyrazine derivatives with antiproliferative activity against melanoma cells.
Garamvölgyi R; Dobos J; Sipos A; Boros S; Illyés E; Baska F; Kékesi L; Szabadkai I; Szántai-Kis C; Kéri G; Őrfi L
Eur J Med Chem; 2016 Jan; 108():623-643. PubMed ID: 26724730
[TBL] [Abstract][Full Text] [Related]
17. Exploration of imidazole and imidazopyridine dimers as anticancer agents: Design, synthesis, and structure-activity relationship study.
Meenakshisundaram S; Manickam M; Pillaiyar T
Arch Pharm (Weinheim); 2019 Dec; 352(12):e1900011. PubMed ID: 31596021
[TBL] [Abstract][Full Text] [Related]
18. Relationship between structure and antineoplastic activity of arylsulfonylhydrazones of 2-formylprydine N-oxide.
Agrawal KC; Sartorelli AC
J Med Chem; 1978 Feb; 21(2):218-21. PubMed ID: 621718
[TBL] [Abstract][Full Text] [Related]
19. Novel dicationic imidazo[1,2-a]pyridines and 5,6,7,8-tetrahydro-imidazo[1,2-a]pyridines as antiprotozoal agents.
Ismail MA; Brun R; Wenzler T; Tanious FA; Wilson WD; Boykin DW
J Med Chem; 2004 Jul; 47(14):3658-64. PubMed ID: 15214792
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of potential anticancer agents. Pyrido[4,3-b][1,4]oxazines and pyrido[4,3-b][1,4]thiazines.
Temple C; Wheeler GP; Comber RN; Elliott RD; Montgomery JA
J Med Chem; 1983 Nov; 26(11):1614-9. PubMed ID: 6631917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]